186 related articles for article (PubMed ID: 24157827)
1. Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.
Tan X; Wang Y; Han Y; Chang W; Su T; Hou J; Xu D; Yu Y; Ma W; Thompson TC; Cao G
Br J Cancer; 2013 Dec; 109(12):3105-15. PubMed ID: 24157827
[TBL] [Abstract][Full Text] [Related]
2. GSTM1 genotype is an independent prognostic factor in clear cell renal cell carcinoma.
Coric VM; Simic TP; Pekmezovic TD; Basta-Jovanovic GM; Savic-Radojevic AR; Radojevic-Skodric SM; Matic MG; Suvakov SR; Dragicevic DP; Radic TM; Dzamic ZM; Pljesa-Ercegovac MS
Urol Oncol; 2017 Jun; 35(6):409-417. PubMed ID: 28284893
[TBL] [Abstract][Full Text] [Related]
3. A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding.
Wang Y; Yang ZY; Chen YH; Li F; Shen H; Yu Y; Huang HY; Shen ZY
J Cell Mol Med; 2018 Jun; 22(6):3005-3015. PubMed ID: 29569387
[TBL] [Abstract][Full Text] [Related]
4. Glutathione transferase genotypes may serve as determinants of risk and prognosis in renal cell carcinoma.
Pljesa-Ercegovac M; Savic-Radojevic A; Coric V; Radic T; Simic T
Biofactors; 2020 Mar; 46(2):229-238. PubMed ID: 31483924
[TBL] [Abstract][Full Text] [Related]
5. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
6. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
7. No association between the GSTM1 null genotype and risk of renal cell carcinoma: a meta-analysis.
Liu R; Wang XH; Liu L; Zhou Q
Asian Pac J Cancer Prev; 2012; 13(7):3109-12. PubMed ID: 22994718
[TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the glutathione S-transferase genes polymorphisms in the risk and prognosis of renal cell carcinomas. Case-control and meta-analysis.
Abid A; Ajaz S; Khan AR; Zehra F; Hasan AS; Sultan G; Mohsin R; Hashmi A; Niamatullah N; Rizvi SA; Mehdi SQ; Khaliq S
Urol Oncol; 2016 Sep; 34(9):419.e1-419.e12. PubMed ID: 27185341
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms.
Karami S; Boffetta P; Rothman N; Hung RJ; Stewart T; Zaridze D; Navritalova M; Mates D; Janout V; Kollarova H; Bencko V; Szeszenia-Dabrowska N; Holcatova I; Mukeria A; Gromiec J; Chanock SJ; Brennan P; Chow WH; Moore LE
Carcinogenesis; 2008 Aug; 29(8):1567-71. PubMed ID: 18566013
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
12. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
[TBL] [Abstract][Full Text] [Related]
13. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
[TBL] [Abstract][Full Text] [Related]
14. Association of glutathione S-transferase M1, T1, and P1 polymorphisms with renal cell carcinoma: evidence from 11 studies.
Jia CY; Liu YJ; Cong XL; Ma YS; Sun R; Fu D; Lv ZW
Tumour Biol; 2014 Apr; 35(4):3867-73. PubMed ID: 24337975
[TBL] [Abstract][Full Text] [Related]
15. Expression-based discovery of variation in the human glutathione S-transferase M3 promoter and functional analysis in a glioma cell line using allele-specific chromatin immunoprecipitation.
Liu X; Campbell MR; Pittman GS; Faulkner EC; Watson MA; Bell DA
Cancer Res; 2005 Jan; 65(1):99-104. PubMed ID: 15665284
[TBL] [Abstract][Full Text] [Related]
16. Glutathione transferase activities in renal carcinomas and adjacent normal renal tissues: factors influencing renal carcinogenesis induced by xenobiotics.
Delbanco EH; Bolt HM; Huber WW; Beken S; Geller F; Philippou S; Brands FH; Brüning T; Thier R
Arch Toxicol; 2001 Jan; 74(11):688-94. PubMed ID: 11218045
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferases as molecular markers of tumour progression and prognosis in renal cell carcinoma.
Searchfield L; Price SA; Betton G; Jasani B; Riccardi D; Griffiths DF
Histopathology; 2011 Jan; 58(2):180-90. PubMed ID: 21255063
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals.
Buzio L; De Palma G; Mozzoni P; Tondel M; Buzio C; Franchini I; Axelson O; Mutti A
Occup Environ Med; 2003 Oct; 60(10):789-93. PubMed ID: 14504370
[TBL] [Abstract][Full Text] [Related]
19. Genetic Analysis Identifies the Role of
Huang CY; Huang SP; Hsueh YM; Chen LC; Lu TL; Bao BY
Cancer Genomics Proteomics; 2020; 17(6):827-833. PubMed ID: 33099483
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]